Skip to main content
Caplight Logo









Pan Cancer T

Pan Cancer T

Private
RotterdamHealthcare & Life Scienceshttps://pancancer-t.com/

Last Round

Debt

Dec 8, 2025

Total Funding Raised

$12.84M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Pan Cancer T is a biotechnology company that develops T cell receptor (TCR) T cell therapies for solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

T-cell receptor therapyTCR-Tsolid tumor therapycell therapyautologous cell therapycancer immunotherapytumor microenvironmentgenetic modificationdrug discovery platformnext-gen immunotherapycontract development and manufacturing organizationCDMObiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pan Cancer T Comparables

Compare Pan Cancer T with similar companies based on industry and business-model similarity.

Pan Cancer T comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Affini-T Therapeutics
83%
Enara Bio
79%
Lion TCR
76%

Pan Cancer T Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 8, 2025
SeedJul 11, 2024
SeedOct 28, 2021
GrantFeb 8, 2021

Key People

Founding team and executive leadership

Rachel Abbott

Chief Executive Officer

Executive Team

Pan Cancer T Investors

Notable investors and investment history

Pan Cancer T investors
InvestorRounds
Swanbridge CapitalSeed, Grant
Thuja CapitalDebt, Seed
Van Herk VenturesDebt, Seed, Grant
InnovationQuarterDebt, Seed
Health~HollandGrant
Erasmus MC O&O Holding B.V.Debt, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 408% MoM.

  • May 15, 2026

    Monthly visitors grew 282% MoM, reaching 447.

Pan Cancer T Filings

Explore SEC and related filing metadata, where available.

Pan Cancer T filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pan Cancer T's valuation, stock price, and market status.

Is Pan Cancer T a public or private company?

Pan Cancer T is a private company.

What is the current stock price of Pan Cancer T?

Pan Cancer T is a private company with no public stock price. No recent secondary market data is available.

How much is Pan Cancer T worth (valuation)?

Valuation information for Pan Cancer T is not publicly available.

Can I buy Pan Cancer T stock?

Pan Cancer T shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pan Cancer T's last funding round?

Pan Cancer T's most recent funding round was Early Funding on December 8, 2025.

Who are the main investors in Pan Cancer T?

Key investors in Pan Cancer T include InnovationQuarter.

Will Pan Cancer T IPO soon?

No public IPO plans have been announced for Pan Cancer T.

How can I track Pan Cancer T secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pan Cancer T's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRotterdam
Employee Range12
Year Founded2020
Last FundingDec 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?